Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-28

Clinical Trial Update: Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and efficacy of clevidipine to control hypertension in patients with aneurysmal subarachnoid hemorrhage; study terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • clevidipine (clevidipine)

Snippet

Sponsor: Henry Ford Health System | Conditions: Subarachnoid Hemorrhage, Hypertension | Phase 2 | Status: TERMINATED | Results posted: 2023-02-28